The number elderly patients with psoriasis is steadily increasing in the Western world, nevertheless they are frequently excluded from biologic clinical trials and described as a high-risk group for adverse events. Thus, there is lack of information concerning safety and effectiveness of available treatments for psoriasis in the elderly, particularly about new biologic systemic drugs.
Elderly psoriatic patients under biological therapies: an Italian experience / Ricceri, F; Bardazzi, F; Chiricozzi, A; Dapavo, P; Ferrara, F; Mugheddu, C; Romanelli, M; Rongioletti, F; Prignano, F. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - 33:1(2019), pp. 143-146. [10.1111/jdv.15139]
Elderly psoriatic patients under biological therapies: an Italian experience
Rongioletti, F;
2019-01-01
Abstract
The number elderly patients with psoriasis is steadily increasing in the Western world, nevertheless they are frequently excluded from biologic clinical trials and described as a high-risk group for adverse events. Thus, there is lack of information concerning safety and effectiveness of available treatments for psoriasis in the elderly, particularly about new biologic systemic drugs.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
